{"id":7027572,"date":"2026-08-04T23:17:08","date_gmt":"2026-08-04T23:17:08","guid":{"rendered":"https:\/\/peraltafinancing.com\/uncategorized\/juvenile-arthritis-awareness-month-finding-help-with-medication-costs\/"},"modified":"2026-08-04T23:17:08","modified_gmt":"2026-08-04T23:17:08","slug":"juvenile-arthritis-awareness-month-finding-help-with-medication-costs","status":"publish","type":"post","link":"https:\/\/fivemor.com\/?p=7027572","title":{"rendered":"Juvenile Arthritis Awareness Month: Finding Help With Medication Costs"},"content":{"rendered":"


\n<\/p>\n

\n

Last Updated on July 21, 2026<\/p>\n

\"A
Specialty biologics can control juvenile arthritis \u2014 copay cards and assistance programs help families afford them.<\/figcaption><\/figure>\n

According to the CDC, about 220,000 children under 18 in the United States have arthritis \u2014 a group of autoimmune and inflammatory conditions that cause joint pain, swelling, and stiffness in kids and teens. The good news is that today\u2019s medications can control the disease and protect growing joints. The challenge is juvenile arthritis medication costs<\/strong>: many of the most effective treatments are specialty biologics that can carry very high price tags. This Juvenile Arthritis Awareness Month, we\u2019re highlighting the treatments used and, more importantly, the programs that help families afford them.<\/p>\n

Understanding juvenile arthritis<\/h2>\n

Juvenile arthritis isn\u2019t a single disease \u2014 it\u2019s an umbrella term for several conditions, the most common being juvenile idiopathic arthritis (JIA). These are autoimmune conditions, meaning the immune system mistakenly attacks the body\u2019s own joints. Left untreated, the inflammation can interfere with a child\u2019s growth and development, which is why early, consistent treatment matters. Care is usually managed by a pediatric rheumatologist and often combines medication, physical therapy, and regular monitoring.<\/p>\n

Common treatments for juvenile arthritis<\/h2>\n

Treatment is typically layered, starting with the least aggressive option that controls the disease:<\/p>\n

NSAIDs and conventional DMARDs.<\/strong> Nonsteroidal anti-inflammatory drugs help with pain and swelling, while conventional disease-modifying antirheumatic drugs (DMARDs) \u2014 most commonly methotrexate \u2014 work to slow the disease itself. Methotrexate is available in several forms, including Otrexup<\/strong><\/a> (a subcutaneous auto-injector).<\/p>\n

Biologic DMARDs.<\/strong> When conventional DMARDs aren\u2019t enough, biologics target specific parts of the immune response. Several are used in children and are commonly prescribed for JIA:<\/p>\n

Because these are specialty medications, they\u2019re also where cost becomes the biggest barrier \u2014 and where the most assistance is available.<\/p>\n

How NeedyMeds can help with juvenile arthritis medication costs<\/h2>\n

Juvenile arthritis medications are backed by manufacturer copay cards, patient assistance programs, and diagnosis-based funds. Patient assistance programs and diagnosis-based funds each have their own pages you can open directly. Copay cards work differently \u2014 they\u2019re shown within each medication\u2019s page \u2014 so throughout this section, click a medication name to see its specific copay-card details.<\/p>\n

If you have commercial insurance: manufacturer copay cards<\/h3>\n

For families with commercial (non-government) insurance, manufacturer savings cards can bring out-of-pocket costs down dramatically \u2014 in many cases to as little as $0 per dose or per month<\/strong>. Click a medication to see its current card details:<\/p>\n